Vectorious Medical Technologies

Excited to present today at prestigious Late-Breaking Science forum at the @escardio #HeartFailure2022, first clinical data of the VECTOR-HF I study which confirms the safety and accuracy of V-LAP in heart microcomputer for remote management of #HeartFailure
@OranKoren @DDamario

In a great presentation and discussion today at #europcr2022, Dr. Eyal Orion, MD discussed how Vectorious is transforming #heartfailure treatment paradigms by allowing patients to remotely monitor their LA pressure via the V-LAP app and take ownership of their disease

Pleasure to be part of #InnovationDublin22! Earlier today Eyal Orion, MD presented the VECTOR-HF II study and how our unique patient self-management approach empowers #heartfailure patients to take control of their disease and improves #patientcare!

@MedTechStrat

We've enrolled the first 6 patients in the VECTOR-HF II Study! These #heartfailure patients will have full visibility of their hearts’ LA pressure via the V-LAP app & can self-adjust their medication to stop further deterioration & avoid hospitalizations. ow.ly/aA3250ITvAH

For the first time in two years, #InnovationDublin22, Europe's largest #medtech partnering and investment conference is back! If you're nearby come hear the latest developments in the VECTOR-HF study! Thursday 28, 2022 09:15-09:25 @MedTechStrat